文献速递乳腺癌支持与姑息治疗

太极气功与认知行为疗法治疗乳腺癌幸存者失眠的比较:一项随机、部分盲法、非劣效性试验

Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial.
PubMed 文献 · J Clin Oncol · 2017-05-10

该随机、部分盲法、非劣效性试验纳入90例乳腺癌幸存者失眠患者,随机分至3个月认知行为疗法(CBT-I)或太极气功(TCC)组,随访至15个月。主要结局为失眠治疗反应率,CBT-I组43.7% vs TCC组46.7%,TCC在15个月、3个月和6个月均非劣效于CBT-I(P=.02、P=.02、P<.01)。两组睡眠质量、睡眠日记指标及相关症状均显著改善(均P<.01),多导睡眠图未见改善。

要点

  • TCC在15个月时失眠治疗反应率46.7%,CBT-I为43.7%,TCC非劣效于CBT-I(P=.02)。
  • 两组睡眠质量、睡眠日记指标及疲劳、嗜睡、抑郁症状均显著改善(均P<.01)。
  • 多导睡眠图指标两组均未见改善。

核心结论

  • CBT-I和TCC均可产生有临床意义的失眠改善,TCC在统计学上非劣效于CBT-I这一行为治疗失眠的金标准。

研究设计与样本

  • 随机、部分盲法、非劣效性试验,2008年4月至2012年7月从洛杉矶社区招募乳腺癌幸存者失眠患者,经过2个月导入期重复基线评估后随机分配至3个月CBT-I或TCC,在第2、3(治疗后)、6、15(随访)个月评估。
  • 筛查145例,随机分配90例(CBT-I组45例,TCC组45例)。

主要发现

  • 15个月时失眠治疗反应率CBT-I组为43.7%,TCC组为46.7%;非劣效性检验显示TCC在15个月(P=.02)、第3个月(P=.02)和第6个月(P<.01)均非劣效于CBT-I。
  • 失眠缓解率CBT-I组为46.2%,TCC组为37.9%。
  • CBT-I和TCC组在睡眠质量、睡眠日记指标及相关症状上均显示大幅改善(均P<.01),但多导睡眠图未见改善,两组改善程度相似。

关键数值与推荐

  • 主要结局为15个月时通过匹兹堡睡眠质量指数评估的失眠治疗反应(即症状显著临床改善)。
  • 次要结局包括临床医生评估的失眠缓解、睡眠质量、睡眠日记衍生的总睡眠时间、入睡潜伏期、睡眠效率和入睡后觉醒时间、多导睡眠图以及疲劳、嗜睡和抑郁症状。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Cognitive behavioral therapy for insomnia (CBT-I) and Tai Chi Chih (TCC), a movement meditation, improve insomnia symptoms. Here, we evaluated whether TCC is noninferior to CBT-I for the treatment of insomnia in survivors of breast cancer. Patients and Methods This was a randomized, partially blinded, noninferiority trial that involved survivors of breast cancer with insomnia who were recruited from the Los Angeles community from April 2008 to July 2012. After a 2-month phase-in period with repeated baseline assessment, participants were randomly assigned to 3 months of CBT-I or TCC and evaluated at months 2, 3 (post-treatment), 6, and 15 (follow-up). Primary outcome was insomnia treatment response-that is, marked clinical improvement of symptoms by the Pittsburgh Sleep Quality Index-at 15 months. Secondary outcomes were clinician-assessed remission of insomnia; sleep quality; total sleep time, sleep onset latency, sleep efficiency, and awake after sleep onset, derived from sleep diaries; polysomnography; and symptoms of fatigue, sleepiness, and depression. Results Of 145 participants who were screened, 90 were randomly assigned (CBT-I: n = 45; TCC: n = 45). The proportion of participants who showed insomnia treatment response at 15 months was 43.7% and 46.7% in CBT-I and TCC, respectively. Tests of noninferiority showed that TCC was noninferior to CBT-I at 15 months ( P = .02) and at months 3 ( P = .02) and 6 ( P < .01). For secondary outcomes, insomnia remission was 46.2% and 37.9% in CBT-I and TCC, respectively. CBT-I and TCC groups showed robust improvements in sleep quality, sleep diary measures, and related symptoms (all P < .01), but not polysomnography, with similar improvements in both groups. Conclusion CBT-I and TCC produce clinically meaningful improvements in insomnia. TCC, a mindful movement meditation, was found to be statistically noninferior to CBT-I, the gold standard for behavioral treatment of insomnia.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Irwin MR, Olmstead R, Carrillo C, et al. Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial. J Clin Oncol. 2017. PMID: 28489508. doi:10.1200/JCO.2016.71.0285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。